RxSight, Inc.
RXSTHealthcareNASDAQMedical Devices
Scan Results
Daily timeframePart of the healthcare sector, RxSight, Inc. (RXST) is listed under Medical Devices. With a market capitalization of $204.5M, it sits in micro-cap territory. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
Market Cap
$204.5M
Beta
1.24
P/E (TTM)
—
P/E (Fwd)
-8.82
EPS (TTM)
$-1.13
EPS (Fwd)
$-0.56
ROE
-17.1%
ROA
-11.2%
Cash
$217.9M
Total Debt
$10.8M
Free CF
-$969,250
52W Change
-67.6%
Annual Financials
Cash vs Debt
RxSight, Inc. holds $217.9M in cash against $10.8M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$969K. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -17.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $49.0M (2022) to $134.5M (2025), reflecting a 174% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence RxSight, Inc.'s trajectory.